Figure 2
Figure 2. Augmented Th1 differentiation in recipients given IL-17−/− donor cells. (A,B) Serum levels of IFN-γ and TNF-α of recipients given WT or IL-17−/− donor spleen cells 5 days after HCT. (C) Mesenteric lymph nodes (MLN) and spleen cells of the recipients given WT or IL-17−/− donor cells were stained for H-2b, CD4, CD8, and intracellular IFN-γ, 13 days after HCT. Gated H-2b+ cells are shown in IFN-γ versus CD4 or CD8. The percentage of IFN-γ+ cells is shown beside the gating boxes. One representative of 4 recipients in each group is shown. (D,E) Means (± SE) of the percentages of IFN-γ+ CD4+ or CD8+ donor T cells in MLN and spleen.

Augmented Th1 differentiation in recipients given IL-17−/− donor cells. (A,B) Serum levels of IFN-γ and TNF-α of recipients given WT or IL-17−/− donor spleen cells 5 days after HCT. (C) Mesenteric lymph nodes (MLN) and spleen cells of the recipients given WT or IL-17−/− donor cells were stained for H-2b, CD4, CD8, and intracellular IFN-γ, 13 days after HCT. Gated H-2b+ cells are shown in IFN-γ versus CD4 or CD8. The percentage of IFN-γ+ cells is shown beside the gating boxes. One representative of 4 recipients in each group is shown. (D,E) Means (± SE) of the percentages of IFN-γ+ CD4+ or CD8+ donor T cells in MLN and spleen.

Close Modal

or Create an Account

Close Modal
Close Modal